Myeloma UK is calling for more data transparency in government efforts to safeguard myeloma patients during the COVID-19 pandemic. This comes after results were released from its COVID-19 survey that sought to examine the rate of COVID-19 infection among myeloma patients, changes to planned treatment due to the viral outbreak, and how the unfolding pandemic is affecting the myeloma community. The survey, conducted from Aug. 28 to Sept. 16, found that 71% of myeloma patients…
You must be logged in to read/download the full post.
The post Myeloma UK Calls for More Data Transparency to Safeguard Patients From COVID-19 appeared first on BioNewsFeeds.